BRK-B vs PFD
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The deterministic health profile is weak, highlighted by a Piotroski F-Score of 3/9, indicating deteriorating fundamental trends. There is a significant valuation gap, with the current price of $473.01 trading at a substantial premium to the growth-based intrinsic value of $217.14. While the company maintains a fortress balance sheet with an exceptional current ratio of 7.07 and low debt/equity (0.19), negative YoY revenue and earnings growth suggest a period of stagnation. The overall outlook is tempered by a bearish technical trend and a very high PEG ratio of 10.06.
PFD presents as a stable income vehicle with a Piotroski F-Score of 5/9, indicating stable financial health. While the Graham Number of $16.53 suggests significant defensive undervaluation and the Price/Book ratio of 0.93 confirms the stock is trading below its asset value, this is offset by negative earnings growth (-13.50%) and a bearish technical trend. The fund is effectively a value play for income seekers rather than a growth investment, as evidenced by the stark contrast between its Graham value and its growth-based intrinsic value of $6.72.
Compare Another Pair
Related Comparisons
BRK-B vs PFD: Head-to-Head Comparison
This page compares Berkshire Hathaway Inc. (BRK-B) and Flaherty & Crumrine Preferred Income Fund Inc. (PFD) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.